CXL for ectasia after LASIK
There is controversy about the effectiveness of CXL for post-keratorefractive ectasia, but Dr. Hafezi said that in his experience, it is as effective…
Prof. Farhad Hafezi
April 15, 2014
There is controversy about the effectiveness of CXL for post-keratorefractive ectasia, but Dr. Hafezi said that in his experience, it is as effective…
Interview on PACK-CXL for corneal infections at the Annual Meeting of the ASCRS
Prof. Hafezi gives an interview on pediatric cross-linking in children and adolescents
Interview on corneal infections at the World Ophthalmology Congress in Tokyo in April 2014.
EMAGine SA, a spin-off company from the University of Geneva and co-founded by Nikki and Farhad Hafezi, is elected amongst the best start-ups in Switzerland in 2014
Children and adolescents with keratoconus may have rapid progression between the ages of 8 and 19 years
An optimized treatment protocol, a miniaturized device that mounts on a slit lamp and a new photosensitizing agent may allow for a faster and more effective application of cross-linking for infectious keratitis in the near future.
